The Arabidopsis clock: time for an about-face?
© BioMed Central Ltd. 2012
Published: 27 April 2012
Three recent studies have altered thinking on the role of TIMING OF CAB EXPRESSION 1 (TOC1), a core element in the plant circadian oscillator.
The circadian clock controls rhythmic changes in processes and development as wide ranging as gene expression and flowering time. This 24-hour time-keeper coordinates many molecular, physiological and metabolic processes to optimize the plant's health and survival in an ever-changing environment. It is the regular cycle of light and dark, warm and cool that serves to keep the oscillator in register with the natural world.
The search for the molecular components of the Arabidopsis central oscillator and for an understanding of how they interrelate has occupied plant clock biologists for at least 20 years. In that time genetic and molecular approaches have been successful in identifying more than 30 genes that either participate directly in the oscillator mechanism or contribute to its maintenance. Two central classes of plant clock genes are: the transcription factors CCA1 and LHY, which have strong morning-phased oscillations in transcript and protein levels (that is, with a peak in the morning); and the five closely related pseudo-response regulator (PRR) proteins, whose defining member is the evening-phased TOC1 (TIMING OF CAB EXPRESSION 1, also called PRR1). Loss of either class causes the clock to run significantly faster, and a molecular connection between the two has been characterized whereby CCA1/LHY bind to the TOC1 promoter, repressing its expression, and TOC1 mutant alleles result in strongly diminished CCA1 and LHY expression levels . This latter finding implied that TOC1 normally activates CCA1/LHY expression, neatly forming an autoregulatory negative feedback loop consistent with models of clock regulation in animals and fungi.
The role of TOC1 as an activating element remained dogma for many years, despite evidence that three other PRR family members work together in a temporal series to sequentially repress CCA1/LHY expression throughout the afternoon and night . However, three new reports [3–5] present compelling experimental evidence and revised computational modeling to show that TOC1 acts extensively as a circadian transcriptional repressor.
TOC1 as a DNA-binding transcription factor and repressor
Approaching the role of TOC1 comprehensively, Huang and co-workers  first performed genome-wide chromatin immunoprecipitation sequencing (ChIP-Seq) to obtain a high-resolution map of TOC1 chromatin occupancy. They identified 772 potential TOC1 target genes, 40% of which were regulated by the circadian clock. Interestingly, the great majority displayed an early morning phase, antiphase to the early evening peak of TOC1 expression . Many known oscillator components were among this group, both morning-phased (CCA1, LHY, PRR9 and PRR7) and evening-phased (GIGANTEA (GI), EARLY FLOWERING 4 (ELF4) and LUX ARRHYTHMO (LUX)) genes, with the latter group including TOC1 itself. Analysis of TOC1-bound sequences identified a G-box (CACGTG)-related motif and a region similar to the evening element previously associated with evening-expressed genes. ChIP validation of specific clock genes showed oscillations in TOC1 chromatin occupancy that coincided with the evening peak of TOC1 protein rhythms.
As chromatin residency does not define function, these findings were extended with experimental manipulations of TOC1 expression. Overexpression of TOC1 was able to suppress all morning (including CCA1) and evening genes tested in a dose-dependent manner, as was transient expression of a dexamethasone-inducible TOC1 construct, suggesting that TOC1 acts as a repressor at all times of the day. Conversely, constitutive reduction in TOC1 expression by RNA interference or the toc1-2 mutant raises the levels of LHY, PRR7, PRR9 and GI expression at times generally correlating with TOC1 protein accumulation. Taken together, Huang et al.  concluded that TOC1 represses a wide range of clock-correlated genes throughout the day, altering the basic model of reciprocal regulation of CCA1/LHY and TOC1 (note these are genes being regulated not proteins) that first founded the molecular basis of the plant circadian oscillator.
Similar conclusions have come through different approaches by Gendron and colleagues . Their work is the first to establish that TOC1 can bind DNA directly, by performing high-resolution ChIP at the CCA1 promoter followed by in vitro electrophoretic mobility shift assays. This new result has resolved the fundamental question of how TOC1, and the closely related PRRs, function molecularly - as DNA-binding proteins. They further identified a TOC1-binding T1ME element within the CCA1 promoter, which contains a motif shared with the morning element and Hormone Up at Dawn element  but differs from the sequences reported by Huang and co-workers .
The T1ME element further differs from a second set of motifs that Gendron et al.  identified through an extensive microarray analysis using an ethanol-inducible TOC1 transgenic line. Here, TOC1 was transiently induced and global gene expression changes in either 12:12 light:dark or constant light cycles were observed over a 24-hour period. In both conditions, almost equal numbers of genes were upregulated and downregulated, potentially positioning TOC1 as both an activator and repressor. Differentially expressed genes were enriched for both the dawn and dusk phases of light transition, corresponding to a potential direct regulation of dawn-phased genes and indirect regulation of dusk genes through effects on dawn targets. When examining cis elements shared among the up- and downregulated genes, three sequence elements were found to be enriched, with each motif associated with a specific change in direction of expression. Although the T1ME element was not among this group, a variant of the G-box, remarkably similar to the sequences reported by Huang et al. , was found among the upregulated genes.
Using transient bombardments and the ethanol-inducible system, Gendron et al.  confirmed the same CCA1 suppression phenotype described by Huang et al.  and showed that this required the DNA-binding capability of TOC1. Using a Gal4-LexA/UAS system, the repressive activity of TOC1 was again confirmed and narrowed down to the amino-terminal PRR domain. This is the same region responsible for TOC1/PRR protein heterodimerization, and it also mediates TOC1 degradation [6, 8], pointing to a complex role for this domain in vivo. The PRR domain alone was insufficient for CCA1 repression, indicating that the carboxy-terminal CCT domain is additionally necessary for this function in vivo.
A dearth of activators
Most lacking in current models is an adequate incorporation of the role of post-transcriptional processes. TOC1 and all the PRR proteins undergo phase-dependent changes in phosphorylation state , and for the most part the significance of these modifications is unknown. In addition, among the PRR family a number of heterodimeric interactions are known. TOC1 can homodimerize, as well as heterodimerize, with PRR3, PRR5 and PRR9 [6, 8]. These interactions have the potential of not only altering DNA-binding affinity, but changing the recruitment of co-factors that could turn repressors into activators, and vice versa. The Gendron et al.  work supports this notion of a more varied and nuanced transcriptional role for TOC1 in the finding of both up- and downregulated gene expression associated with its expression.
Current models also poorly explain findings reported in triple and higher-order mutant backgrounds. Most notably, the nearly complete removal of the PRR repressor family - the prr9 prr7 prr5 toc1 mutant - might be expected to cause a strong and consistent upregulation of CCA1 and LHY. Although overall clock gene expression becomes arrhythmic and CCA1 levels do rise significantly during the normal trough times, the normal strong peak of CCA1 expression around dawn is entirely eliminated, with expression at this time four- to five-fold lower in the quadruple (or prr9 prr7 prr5 triple) mutant than in wild type . Not all clock-controlled transcripts descend to trough levels in these mutants - some flatten towards peak expression levels - further emphasizing the likely incomplete nature of current clock mechanism models.
Finally, a difficult but real complication in dissecting the clock mechanism is the strong intersection between light signaling and the circadian system. Huang et al.  performed the majority of their work under light:dark cycles of either 12:12 or 8:16, overlaying photic oscillations onto the circadian mechanism. Their evidence is strong that TOC1 represses many genes under these conditions, but in extended constant light CCA1 and LHY levels in toc1 mutants do drop markedly. Experiments using thermal cycles (warm:cold) to maintain entrainment in constant light or darkness may be necessary to unravel these closely connected processes.
Taken together, the genomic and molecular approaches used in these recent studies both clarify and complicate our understanding of the basis of the plant circadian system. TOC1 has been cast into a much wider role than previously expected, and there is now a fuller appreciation of how pervasive its effect is both within the circadian oscillator itself and in connection to physiological, metabolic and developmental pathways.
This work was supported by funds from the World Class University Program (No. R31-2008-000-10105-0) and the National Institute of Health (R01GM093285).
- Alabadi D, Oyama T, Yanovsky MJ, Harmon FG, Mas P, Kay SA: Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock. Science. 2001, 293: 880-883. 10.1126/science.1061320.PubMedView ArticleGoogle Scholar
- Nakamichi N, Kiba T, Henriques R, Mizuno T, Chua NH, Sakakibara H: PSEUDO-RESPONSE REGULATORS 9, 7, and 5 are transcriptional repressors in the Arabidopsis circadian clock. Plant Cell. 2010, 22: 594-605. 10.1105/tpc.109.072892.PubMedPubMed CentralView ArticleGoogle Scholar
- Huang W, Perez-Garcia P, Pokhilko A, Millar AJ, Antoshechkin I, Riechmann JL, Mas P: Mapping the core of the Arabidopsis circadian clock defines the network structure of the oscillator. Science. 2012, 336: 75-79. 10.1126/science.1219075.PubMedView ArticleGoogle Scholar
- Gendron JM, Pruneda-Paz JL, Doherty CJ, Gross AM, Kang SE, Kay SA: Arabidopsis circadian clock protein, TOC1, is a DNA-binding transcription factor. Proc Natl Acad Sci USA. 2012, 109: 3167-3172. 10.1073/pnas.1200355109.PubMedPubMed CentralView ArticleGoogle Scholar
- Pokhilko A, Fernandez AP, Edwards KD, Southern MM, Halliday KJ, Millar AJ: The clock gene circuit in Arabidopsis includes a repressilator with additional feedback loops. Mol Syst Biol. 2012, 8: 574-PubMedPubMed CentralView ArticleGoogle Scholar
- Fujiwara S, Wang L, Han L, Suh SS, Salome PA, McClung CR, Somers DE: Post-translational regulation of the Arabidopsis circadian clock through selective proteolysis and phosphorylation of pseudo- response regulator proteins. J Biol Chem. 2008, 283: 23073-23083. 10.1074/jbc.M803471200.PubMedView ArticleGoogle Scholar
- Michael TP, Breton G, Hazen SP, Priest H, Mockler TC, Kay SA, Chory J: A morning-specific phytohormone gene expression program underlying rhythmic plant growth. PLoS Biol. 2008, 6: e225-10.1371/journal.pbio.0060225.PubMedPubMed CentralView ArticleGoogle Scholar
- Wang L, Fujiwara S, Somers DE: PRR5 regulates phosphorylation, nuclear import and subnuclear localization of TOC1 in the Arabidopsis circadian clock. EMBO J. 2010, 29: 1903-1915. 10.1038/emboj.2010.76.PubMedPubMed CentralView ArticleGoogle Scholar
- Purcell O, Savery NJ, Grierson CS, di Bernardo M: A comparative analysis of synthetic genetic oscillators. J R Soc Interface. 2010, 7: 1503-1524. 10.1098/rsif.2010.0183.PubMedPubMed CentralView ArticleGoogle Scholar
- Yamashino T, Ito S, Niwa Y, Kunihiro A, Nakamichi N, Mizuno T: Involvement of Arabidopsis clock-associated pseudo-response regulators in diurnal oscillations of gene expression in the presence of environmental time cues. Plant Cell Physiol. 2008, 49: 1839-1850. 10.1093/pcp/pcn165.PubMedView ArticleGoogle Scholar